Parenteral administration of progestin Nestorone® to lactating cynomolgus monkeys: An ideal hormonal contraceptive at lactation?

Human Reproduction

Volumn 14, Issue 8, 1999, Pages 1993-1997

  Heikinheimo, O ^d   Ranta, S ^e   Moo Young, A ^a   Lahteenmaki P ^e   Gordon, K ^b,c  

^a POPULATION COUNCIL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Balance Pharmaceuticals   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NONE

Author keywords

Distribution; Lactation; Pharmacokinetics; Progestin only contraception; Radioimmunoassay

Indexed keywords

ELCOMETRINE; GESTAGEN; PROLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTRACEPTION; DRUG DISTRIBUTION; FEMALE; LACTATION; MATERNAL SERUM; MILK; MONKEY; NONHUMAN; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; MACACA FASCICULARIS; NES;

EID: 0032790548     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.8.1993     Document Type: Article

References (21)

1. Chaudhury, R.R., Chompootaweep, S., Dusitsin, N. et al. (1977) The release of prolactin by medroxy-progesterone acetate in human subjects. Br. J. Pharmacol., 59, 433-434.
2. Coutinho, E., DaSilva, A.R., Carreira, C. and Sivin, I. (1981) Long-term contraception with a single implant of the progestin ST-1435. Fertil. Steril., 36, 737-740.
3. Díaz, S. and Croxatto, H.B. (1993) Contraception in lactating women. Curr. Opin. Obstet. Gynecol., 5, 815-822.
4. Díaz, S., Rodríguez, G., Peralta, O. et al. (1988) Lactational amenorrhea and the recovery of ovulation and fertility in fully nursing Chilean women. Contraception, 38, 53-67.
5. Gordon, K., Hodgen, G. and Richardson, D. (1992) Postpartum lactational anovulation in a nonhuman primate (Macaca fascicularis): endogenous opiate mediation of suckling-induced hyperprolactinemia. J. Clin. Endocrinol. Metab., 75, 59-67.
6. Haukkamaa, M., Laurikka-Routti, M. and Heikinheimo, O. (1991) Transdermal absorption of the progestin ST-1435: therapeutic serum steroid concentrations and high excretion of the steroid in saliva. Contraception, 44, 269-276.
7. Haukkamaa, M., Laurikka-Routti, M., Heikinheimo, O. and Moo-Young, A. (1992) Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study. Contraception, 45, 49-55.
8. Heikinheimo, O., Noé, G., Haukkamaa, M. and Lähteenmäki, P. (1994) The progestin ST-1435 - rapid metabolism in man. Contraception, 50, 275-289.
9. Heikkilä, M., Haukkamaa, M. and Luukkainen, T. (1982) Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. Contraception, 25, 41-49.
10. Koetsawang, S., Nukulkarn, P., Fotherby, K. et al. (1982) Transfer of contraceptive steroids in milk of women using long-acting gestagens. Contraception, 25, 321-331.
11. Kurunmäki, H., Toivonen, J., Lähteenmäki, P.L.A. and Luukkainen, T. (1984) Intracervical release of ST-1435 for contraception. Contraception, 29, 411-421.
12. Laurikka-Routti, M., Haukkamaa, M. and Heikinheimo, O. (1990) A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry. Contraception, 41, 111-120.
13. Lähteenmäki, P.L.A. (1986) Contraceptive action of a synthetic progestin, ST-1435 (Thesis). University of Helsinki, Helsinki, Finland.
14. Lähteenmäki, P., Weiner, E., Lähteenmäki, P.L.A. et al. (1981) Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma concentrations of ST-1435. Contraception, 23, 63-75.
15. Lähteenmäki, P.L.A., Weiner, E., Lähteenmäki, P. et al. (1982) Pituitary and ovarian function during contraception with one subcutaneous implant releasing the progestin ST-1435. Contraception, 25, 299-306.
16. Lähteenmäki, P.L.A., Hammond, G. and Luukkainen, T. (1983) Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities. Acta Endocrinol., 102, 307-313.
17. Lähteenmäki, P.L.A., Díaz, S., Miranda, P. et al. (1990) Milk and plasma concentrations of the progestin ST-1435 in women treated parenterally with ST-1435. Contraception, 42, 555-562.
18. Nilsson, S., Nygren, K-G. and Johansson, E.D.B. (1977) d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am. J. Obstet. Gynecol., 129, 178-184.
19. Thapa, S., Short, R. and Potts, M. (1988) Breast feeding, birth spacing and their effects on child survival. Nature, 335, 679-682.
20. WHO (1994) World Health Organization Task Force for Epidemiological Research on Reproductive Health: Special Programme of Research, Development and Research Training in Human Reproduction Progestogenonly contraceptives during lactation. I. Infant growth. Contraception, 50, 35-53.
21. WHO (1998) World Health Organization Task Force on Methods for the Natural Regulation of Fertility; The World Health Organization Multinational Study of Breast-feeding and Lactational Amenorrhea. I. Description of infant feeding patterns and of the return of menses. Fertil. Steril., 70, 448-460.